Clinical validity and utility of genetic risk scores in prostate cancer

Current issues related to prostate cancer (PCa) clinical care (e.g., over-screening, over-diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can be combined with family history (FH) to stratify disease risk among men in the general population. Since 2007, genome-...

Descripción completa

Detalles Bibliográficos
Autores principales: Helfand, Brian T, Kearns, James, Conran, Carly, Xu, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955171/
https://www.ncbi.nlm.nih.gov/pubmed/27297129
http://dx.doi.org/10.4103/1008-682X.182981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955171/
https://www.ncbi.nlm.nih.gov/pubmed/27297129
http://dx.doi.org/10.4103/1008-682X.182981

Ejemplares similares